INSP gains dedicated CPT codes for Inspire V system, effective Jan 2028
Inspire Medical Systems secured AMA approval for new Category I CPT codes specifically describing the Inspire V hypoglossal nerve stimulation system, effective January 1, 2028, potentially improving reimbursement clarity and billing efficiency.
How Oyticker scores a story: impact and confidence describe the information, not a probability that a price moves.
What happened
The AMA CPT Editorial Panel approved a new set of Category I Current Procedural Terminology codes that specifically describe and include the Inspire V system for hypoglossal nerve stimulation in obstructive sleep apnea treatment. Implementation is scheduled for January 1, 2028.
Why it matters
Dedicated CPT codes reduce billing ambiguity, streamline claims processing, and may improve reimbursement rates by eliminating off-label or bundled coding. This administrative clarity typically accelerates adoption among providers and payers, supporting volume growth and revenue predictability for the device manufacturer.
Market transmission
First-order: improved billing efficiency and reduced claim denials lower provider friction and increase procedure volume. Second-order: clearer reimbursement pathways may encourage payer coverage expansion and reduce prior-authorization delays, expanding addressable market and improving cash conversion cycles.
What to watch
Confirmation: Q1 2028 and beyond procedure volume trends, payer coverage announcements, and management commentary on reimbursement environment. Invalidation: if payers do not expand coverage or if reimbursement rates remain compressed despite code clarity.
Source:GlobeNewswire US
Oyticker provides market information and analysis for educational purposes. It is not investment advice: you remain responsible for your own decisions.